Correlation Between Evogene and Purple Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evogene and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Purple Biotech, you can compare the effects of market volatilities on Evogene and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Purple Biotech.

Diversification Opportunities for Evogene and Purple Biotech

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Evogene and Purple is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Evogene i.e., Evogene and Purple Biotech go up and down completely randomly.

Pair Corralation between Evogene and Purple Biotech

Given the investment horizon of 90 days Evogene is expected to generate 0.83 times more return on investment than Purple Biotech. However, Evogene is 1.2 times less risky than Purple Biotech. It trades about -0.08 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.1 per unit of risk. If you would invest  595.00  in Evogene on August 24, 2024 and sell it today you would lose (435.00) from holding Evogene or give up 73.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Evogene  vs.  Purple Biotech

 Performance 
       Timeline  
Evogene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evogene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Evogene and Purple Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evogene and Purple Biotech

The main advantage of trading using opposite Evogene and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.
The idea behind Evogene and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency